By Erin Harris, Editor-In-Chief, Cell & Gene
Follow Me On Twitter @ErinHarris_1
According to the American Society of Gene and Cell Therapy (ASGCT), gene therapy involves the transfer of genetic material, usually in a carrier or vector, and the uptake of the gene into the appropriate cells of the body. Cell therapy, on the other hand, involves the transfer of cells with the relevant function into the patient. There is crossover between the two, as some protocols utilize both gene therapy and cell therapy. But the differences between gene therapy and cell therapy are vast, and as such, it is important to address and discuss them separately. And so, to garner a clear outlook for 2022 and beyond, I spoke to André Choulika, CEO at Cellectis, and Michael Mehler, director, global site operations, at Immatics. Choulika provided me with perspective for gene therapy, and Mehler provided me with the same for cell therapy. Here’s what they had to say.